Skip to main content
Log in

Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked

  • Published:
Surgical Endoscopy And Other Interventional Techniques Aims and scope Submit manuscript



In August 2004, the United Kingdom Department of Health advisory body published dyspepsia referral guidelines for primary care practitioners. These guidelines advised empiric treatment with antisecretory medications and referral for endoscopy only in the presence of alarm symptoms. The current study aimed to evaluate the effect of these guidelines on the detection of esophagogastric cancer.


The study reviewed a prospectively compiled database of 4,018 subjects who underwent open access gastroscopy during the years 1990 to 1998. The main outcome measures for the study were cancer detection rates, International Union Against Cancer (UICC) stage, and survival.


Gastroscopy identified esophagogastric carcinoma in 123 (3%) of the 4,018 subjects. Of these 123 patients, 104 (85%) with esophagogastric cancer had “alarm” symptoms (anemia, mass, dysphagia, weight loss, vomiting) and would have satisfied the referral criteria. The remaining 15% would not have been referred for initial endoscopic assessment because their symptoms were those of uncomplicated “benign” dyspepsia. The patients with “alarm” symptoms had a significantly more advanced tumor stage (metastatic disease in 47% vs 11%; p < 0.001), were less likely to undergo surgical resection (50% vs 95%; p < 0.001), and had a poorer survival (median, 11 vs 39 months; p = 0.01) than their counterparts without such symptoms.


The use of alarm symptoms to select dyspeptics for endoscopy identifies patients with advanced and usually incurable esophagogastric cancer. Patients with early curable cancers often have only dyspeptic symptoms, and their diagnosis will be delayed until the symptoms of advanced cancer develop.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others


  1. Blackshaw GR, Barry JD, Edwards P, Allison MC, Lewis WG (2003) Open-access gastroscopy is associated with improved outcomes in gastric cancer. Eur J Gastroenterol Hepatol 15: 1333–1337

    Article  PubMed  Google Scholar 

  2. Bytzer P, Hansen JM, Schaffalitsky de Muckadell OB (1994) Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 343: 811–816

    Article  PubMed  CAS  Google Scholar 

  3. Ferguson MK, Durkin A (2002) Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 6: 29–35

    Article  PubMed  Google Scholar 

  4. Fountoulakis A, Zafirellis KD, Dolan K, Dexter SP, Martin IG, Sue-Ling HM (2004) Effect of surveillance on the clinical outcome of esophageal cancer. Br J Surg 91: 997–1003

    Article  PubMed  CAS  Google Scholar 

  5. Fransen GA, Janssen MJ, Muris JW, Laheij RJ, Jansen JB (2004) Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy. Aliment Pharmacol Ther 20: 1045–1052

    Article  PubMed  CAS  Google Scholar 

  6. Johansson J, Johnsson F, Walther B, Willen R, Stael von Holstein C, Zilling T (1996) Adenocarcinoma in the distal esophagus with and without Barrett esophagus: differences in symptoms and survival rates. Arch Surg 131: 708–713

    PubMed  CAS  Google Scholar 

  7. Maconi G, Kurihara H, Panizzo V, Russo A, Cristaldi M, Marrelli D, Roviello F, de Manzoni G, Di Leo A, Morgagni P, Bechi P, Bianchi Porro G, Taschieri AM, Italian Research Group for Gastric Cancer (2003) Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol 38: 1249–1255

    Article  PubMed  CAS  Google Scholar 

  8. Meineche-Schmidt V, Jorgensen T (2002) “Alarm symptoms” in patients with dyspepsia: a three-year prospective study from general practice. Scand J Gastroenterol 37: 999–1007

    Article  PubMed  CAS  Google Scholar 

  9. National Institute for Clinical Excellence (2004) Dyspepsia: managing dyspepsia in adults in primary care. National Institute for Health and Clinical Excellence, Holborn, London, WC1V 6NA, UK.

  10. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR (1994) Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108: 813–822

    PubMed  CAS  Google Scholar 

  11. Sue-Ling HM, Martin I, Griffith J, Ward DC, Quirke P, Dixon MF, Axon AT, McMahon MJ, Johnston D (1992) Early gastric cancer: 46 patients treated in one surgical department. Gut 33: 1318–1322

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to S. M. Griffin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowrey, D.J., Griffin, S.M., Wayman, J. et al. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc 20, 1725–1728 (2006).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: